(Q39442816)

12 September 2017

title

An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation (English)

1 reference

12 September 2017

1 reference

Xiaobing Liu

1

1 reference

12 September 2017

Wenqing Qi

2

1 reference

12 September 2017

Laurence S Cooke

3

1 reference

12 September 2017

E M Kithsiri Wijeratne

4

1 reference

12 September 2017

Ya-Ming Xu

5

1 reference

12 September 2017

Marilyn T Marron

6

1 reference

12 September 2017

A A Leslie Gunatilaka

7

1 reference

12 September 2017

Daruka Mahadevan

8

1 reference

12 September 2017

publication date

1 December 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

29

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

668-675

1 reference

Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

2,3-Dihydrowithaferin A-3beta-O-sulfate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Actin microfilament aggregation induced by withaferin A is mediated by annexin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Withaferin A targets heat shock protein 90 in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Gene expression and integrated stress response in HepG2/C3A cells cultured in amino acid deficient medium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Mechanisms of cell protection by heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Heme oxygenase-1 in tumors: is it a false friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2011.626478

10.3109/07357907.2011.626478

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference